- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging Target-Based Paradigms to Prevent and Treat Migraine
Authors
Keywords
-
Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 93, Issue 1, Pages 78-85
Publisher
Springer Nature
Online
2012-12-05
DOI
10.1038/clpt.2012.198
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and tolerability of lasmiditan, an oral 5-HT1F receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study
- (2012) Markus Färkkilä et al. LANCET NEUROLOGY
- Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults: Table 1
- (2012) S.D. Silberstein et al. NEUROLOGY
- Discovery of BMS-846372, a Potent and Orally Active Human CGRP Receptor Antagonist for the Treatment of Migraine
- (2012) Guanglin Luo et al. ACS Medicinal Chemistry Letters
- Emerging migraine treatments and drug targets
- (2011) Jes Olesen et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Lack of efficacy of the selective iNOS inhibitor GW274150 in prophylaxis of migraine headache
- (2010) Hans Olav Høivik et al. CEPHALALGIA
- Preclinical pharmacological profile of the selective 5-HT1F receptor agonist lasmiditan
- (2010) David L Nelson et al. CEPHALALGIA
- BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study
- (2010) Hans-Christoph Diener et al. CEPHALALGIA
- Excellent Tolerability But Relatively Low Initial Clinical Efficacy of Telcagepant in Migraine
- (2010) Peer Tfelt-Hansen HEADACHE
- A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura
- (2010) Ronald G Lafrenière et al. NATURE MEDICINE
- Molecular Background of Leak K+ Currents: Two-Pore Domain Potassium Channels
- (2010) Péter Enyedi et al. PHYSIOLOGICAL REVIEWS
- Optimization of azepanone calcitonin gene-related peptide (CGRP) receptor antagonists: Development of novel spiropiperidines
- (2009) Christopher S. Burgey et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Randomized, controlled trial of telcagepant for the acute treatment of migraine
- (2009) K. M. Connor et al. NEUROLOGY
- CGRP function-blocking antibodies inhibit neurogenic vasodilatation without affecting heart rate or arterial blood pressure in the rat
- (2008) J Zeller et al. BRITISH JOURNAL OF PHARMACOLOGY
- Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial
- (2008) Tony W Ho et al. LANCET
- Roles of TRESK, a novel two-pore domain K+ channel, in pain pathway and general anesthesia
- (2008) Dong-Yue Huang et al. Neuroscience Bulletin
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started